Sign in

CIK 0001850767 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Accustem Sciences Inc.

Sign in to watch
Ticker
ACUT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
442070661000
Business address
5 PENN PLAZA, 19TH FLOOR, #1954, NEW YORK, NY, 10001
Former names
AccuStem Sciences Ltd
  1. 4 Open-market buy Director bought 2,400 shares at an average $1.02 ($2,440)
  2. 4 Open-market buy Director bought 37,196 shares at an average $0.50 ($18,462)
  3. 4 Open-market buy Director bought 38,000 shares at an average $0.67 ($25,285)
  4. 4 Open-market buy Director bought 152,802 shares at an average $0.51 ($78,291)
  5. 4 Open-market buy Director bought 100,000 shares at $0.38 ($38,100)
  6. 4 Open-market buy Director bought 5,000 shares at $1.40 ($7,000)
  7. 4 Open-market buy Director bought 3,729 shares at $1.42 ($5,295)
  8. 4 Open-market buy Director bought 24,500 shares at $1.05 ($25,725)
  9. 4 Open-market buy Director bought 10,000 shares at $0.79 ($7,900)
  10. 4 Open-market buy Director bought 20,000 shares at $0.50 ($10,000)
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy Director bought 9,447 shares at an average $1.43 ($13,491)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership

Page 1 of 1 · 17 filings